wayground logo

Free Printable Worksheets

Font size

S
M
L
XL
Worksheets

Chronic Heart Failure Ch 31

Total questions: 97

Worksheet time: 49mins

Name
Class
Date
1.

What is the primary function of the left ventricle in the context of heart failure?

a)

To filter blood

b)

To pump oxygen-rich blood to the body

c)

To produce red blood cells

d)

To regulate blood pressure

2.

Which of the following is NOT listed as a drug treatment for chronic heart failure in the table of contents?

a)

Beta-Blockers

b)

Loop Diuretics

c)

Antibiotics

d)

Digoxin

3.

According to the contents, which section would you refer to for information on drugs that may worsen heart failure?

a)

Pathophysiology

b)

Drug-Induced Heart Failure

c)

Lifestyle Management

d)

Iron Replacement Therapy

4.

If a patient needs information on compensatory mechanisms in heart failure, which section should they consult?

a)

Diagnosis

b)

Pathophysiology

c)

Drug Treatment

d)

Potassium Oral Supplementation

5.

Which of the following is a key counseling point for chronic heart failure management, as indicated in the contents?

a)

Key Counseling Points

b)

Classification Systems

c)

Ejection Fraction

d)

Vericiguat

6.

A student wants to learn about the role of ACE inhibitors in heart failure. Which section should they look at?

a)

Beta-Blockers

b)

Renin-Angiotensin-Aldosterone System Inhibitors

c)

Loop Diuretics

d)

Iron Replacement Therapy

7.

Based on the table of contents, which of the following is a lifestyle management strategy for chronic heart failure?

a)

Digoxin therapy

b)

Potassium oral supplementation

c)

Lifestyle Management

d)

Sodium-Glucose Cotransporter 2 Inhibitors

8.

Which of the following is a common cause of heart failure (HF)?

a)

Ischemic conditions such as myocardial infarction (MI)

b)

Excessive exercise

c)

High protein diet

d)

Frequent headaches

9.

What is the primary problem in heart failure?

a)

The heart is unable to supply sufficient oxygen-rich blood to the body

b)

The heart beats too fast

c)

The heart produces excess hormones

d)

The heart pumps too much blood

10.

Which lab/biomarker is used to distinguish between cardiac and non-cardiac causes of dyspnea?

a)

BNP and proBNP

b)

Hemoglobin

c)

Troponin

d)

Creatinine

11.

Which of the following is a left-sided sign or symptom of heart failure?

a)

Orthopnea (shortness of breath when lying flat)

b)

Hepatomegaly (enlarged liver)

c)

Jugular venous distention (JVD)

d)

Ascites (abdominal fluid accumulation)

12.

Which general sign or symptom is commonly seen in heart failure?

a)

Dyspnea (shortness of breath at rest or during exertion)

b)

Skin rash

c)

Blurred vision

d)

Hair loss

13.

Which right-sided sign or symptom is associated with heart failure?

a)

Peripheral edema

b)

Paroxysmal nocturnal dyspnea

c)

S3 gallop

d)

Hypoperfusion

14.

What does an ejection fraction (EF) less than 40% indicate?

a)

Systolic dysfunction or heart failure with reduced ejection fraction (HFrEF)

b)

Normal heart function

c)

Diastolic dysfunction only

d)

Increased cardiac output

15.

Which diagnostic procedure is commonly used to estimate left ventricular ejection fraction (LVEF) in suspected heart failure?

a)

Echocardiography (echo)

b)

Chest X-ray

c)

Electrocardiogram (ECG)

d)

Blood pressure measurement

16.

A patient presents with crackling sounds heard on lung exam and nocturnal cough. Which type of heart failure symptoms are these?

a)

Left-sided symptoms

b)

Right-sided symptoms

c)

General symptoms

d)

Non-cardiac symptoms

17.

Which of the following is NOT a general sign or symptom of heart failure?

a)

Fatigue and weakness

b)

Reduced exercise capacity

c)

Skin rash

d)

Cough

18.

Which term is used for heart failure when the left ventricular ejection fraction (LVEF) is 41-49%?

a)

Heart Failure with Preserved EF (HFpEF)

b)

Heart Failure with Mildly Reduced EF (HFmrEF)

c)

Heart Failure with Reduced EF (HFrEF)

d)

Heart Failure with Improved EF (HFimpEF)

19.

What is the primary problem in Heart Failure with Preserved EF (HFpEF)?

a)

Impaired ability to eject blood during systole

b)

Impaired ventricular relaxation and filling during diastole

c)

Likely mixed systolic and diastolic dysfunction

d)

EF improved with treatment

20.

According to the ACC/AHA staging system, what stage describes patients at risk for heart failure but without symptoms, structural heart disease, or elevated biomarkers?

a)

Stage A

b)

Stage B

c)

Stage C

d)

Stage D

21.

Which NYHA functional class describes patients who are unable to perform physical activity without heart failure symptoms, or whose symptoms occur at rest?

a)

Class I

b)

Class II

c)

Class III

d)

Class IV

22.

What is the main purpose of the staging system recommended by the American College of Cardiology and American Heart Association for heart failure?

a)

To diagnose heart failure

b)

To guide treatment and slow progression of structural heart disease

c)

To measure blood pressure

d)

To assess cholesterol levels

23.

A patient with structural heart disease and prior or current symptoms of heart failure, such as shortness of breath and reduced exercise tolerance, would be classified as which ACC/AHA stage?

a)

Stage A

b)

Stage B

c)

Stage C

d)

Stage D

24.

Which NYHA functional class is characterized by slight limitation of physical activity, where ordinary physical activity results in heart failure symptoms?

a)

Class I

b)

Class II

c)

Class III

d)

Class IV

25.

A patient with advanced (refractory) heart failure and severe symptoms or recurrent hospitalizations despite maximal treatment is classified as which ACC/AHA stage?

a)

Stage A

b)

Stage B

c)

Stage C

d)

Stage D

26.

Which of the following is NOT a primary problem associated with heart failure with reduced ejection fraction (HFrEF)?

a)

Impaired ability to eject blood during systole

b)

Impaired ventricular relaxation and filling during diastole

c)

Systolic dysfunction

d)

EF improved with treatment

27.

In the NYHA functional classification, what does Class III indicate?

a)

No limitations of physical activity

b)

Slight limitation of physical activity

c)

Marked limitation of physical activity; minimal exertion causes symptoms

d)

Unable to perform physical activity without symptoms

28.

Which of the following best defines cardiac output (CO)?

a)

The volume of blood pumped by the heart in one minute

b)

The pressure exerted by blood on vessel walls

c)

The amount of oxygen carried by red blood cells

d)

The rate of electrical impulses in the heart

29.

Which neurohormonal pathway is activated to increase blood volume and force of contractions in heart failure with reduced ejection fraction (HFrEF)?

a)

Renin-angiotensin-aldosterone system (RAAS)

b)

Parasympathetic nervous system

c)

Dopaminergic pathway

d)

Cholinergic pathway

30.

Which drug class is preferred in heart failure for antiarrhythmic therapy?

a)

Amiodarone and dofetilide

b)

Flecainide and dronedarone

c)

Diltiazem and verapamil

d)

Thiazolidinediones

31.

What is the effect of angiotensin II in the RAAS pathway?

a)

Causes systemic vasoconstriction and stimulates aldosterone release

b)

Increases potassium excretion only

c)

Decreases blood pressure by vasodilation

d)

Inhibits sodium and water retention

32.

Which of the following is a recommended lifestyle management strategy for patients with heart failure?

a)

Monitor and document body weight daily

b)

Increase sodium intake

c)

Avoid all forms of exercise

d)

Ignore weight changes

33.

Which natural product may improve heart failure symptoms according to the document?

a)

Hawthorn and coenzyme Q10

b)

Vitamin C and zinc

c)

Garlic and ginseng

d)

Echinacea and melatonin

34.

A patient with heart failure gains 3 pounds in one day. What should be done according to the action plan?

a)

Notify the provider

b)

Ignore the weight gain

c)

Increase sodium intake

d)

Stop documenting body weight

35.

Which of the following drugs can cause or worsen heart failure?

a)

Diltiazem and verapamil

b)

Lisinopril and losartan

c)

Metoprolol and carvedilol

d)

Atorvastatin and simvastatin

36.

How does norepinephrine (NE) and epinephrine (Epi) affect the heart in heart failure?

a)

Increase heart rate, contractility (positive inotropy), and vasoconstriction

b)

Decrease heart rate and cause vasodilation

c)

Inhibit contractility and reduce blood pressure

d)

Cause sodium and water retention

37.

Why is omega-3 fatty acid supplementation considered in heart failure management?

a)

It is reasonable to lower mortality and cardiovascular hospitalizations

b)

It increases blood pressure

c)

It causes fluid retention

d)

It worsens heart failure symptoms

38.

Which of the following drug classes provides a mortality benefit in the treatment of heart failure with reduced ejection fraction (HFrEF)?

a)

Loop diuretics

b)

Digoxin

c)

Beta-blockers

d)

Hydralazine

39.

What is the preferred first-line treatment for all patients with HFrEF according to guideline-directed medical therapy (GDMT)?

a)

Digoxin

b)

Angiotensin receptor and neprilysin inhibitor (ARNI)

c)

Loop diuretics

d)

Ivabradine

40.

Which medication is recommended for self-identified Black patients with HFrEF who remain symptomatic on optimized first-line medications?

a)

Sacubitril

b)

Hydralazine/isosorbide dinitrate

c)

SGLT2 inhibitor

d)

Beta-blocker

41.

Loop diuretics in HFrEF treatment primarily provide which of the following benefits?

a)

Decreased mortality

b)

Increased cardiac output

c)

Decreased symptoms by reducing blood volume, edema, and congestion

d)

Increased contractility

42.

Which of the following drugs is associated with a reduction in risk of hospitalization and cardiovascular death after recent heart failure hospitalization or need for IV diuretics?

a)

Vericiguat

b)

Digoxin

c)

Beta-blocker

d)

Loop diuretic

43.

Explain why medications for HFrEF may be started simultaneously at low doses or sequentially. What is the clinical rationale for this approach?

a)

To avoid drug interactions and maximize patient compliance

b)

To achieve target doses without causing adverse effects and to ensure patient tolerance

c)

To reduce the cost of therapy

d)

To increase the speed of symptom relief

44.

A patient with HFrEF is started on a beta-blocker, ACE inhibitor, and loop diuretic. After several weeks, the patient continues to have symptoms and meets criteria for additional therapy. Which medication could be added to reduce risk of hospitalization and CV death, provided heart rate and rhythm criteria are met?

a)

Digoxin

b)

Ivabradine

c)

Hydralazine

d)

Sacubitril

45.

Which class of drugs is recommended first line in all heart failure (HF) patients regardless of symptom severity?

a)

Renin-angiotensin-aldosterone system inhibitors (RAAS inhibitors)

b)

Beta-blockers

c)

Diuretics

d)

Calcium channel blockers

46.

What is the main benefit of SGLT2 inhibitors in patients with HFrEF or HFpEF?

a)

Decreasing HF hospitalizations and cardiovascular mortality

b)

Increasing blood pressure

c)

Reducing cholesterol levels

d)

Improving kidney function

47.

Why should more than one RAAS inhibitor not be used together?

a)

Increased risk of hyperkalemia and renal insufficiency

b)

Increased risk of hypertension

c)

Increased risk of bradycardia

d)

Increased risk of diabetes

48.

Which drug combination is preferred over ACE inhibitor or ARB alone due to improved outcomes in heart failure?

a)

Sacubitril/valsartan (Entresto)

b)

Lisinopril/spironolactone

c)

Metoprolol/losartan

d)

Furosemide/digoxin

49.

What is the role of neprilysin in heart failure treatment?

a)

Degrades vasodilatory peptides

b)

Increases sodium retention

c)

Stimulates aldosterone production

d)

Blocks beta-adrenergic receptors

50.

Which of the following is a contraindication for sacubitril/valsartan (Entresto)?

a)

History of angioedema

b)

History of hypertension

c)

History of diabetes

d)

History of asthma

51.

A patient is switching from an ACE inhibitor to sacubitril/valsartan. What is required before starting sacubitril/valsartan?

a)

36-hour washout period

b)

Immediate switch without delay

c)

12-hour washout period

d)

No washout required

52.

Which side effect is associated with sacubitril/valsartan due to increased bradykinin levels?

a)

Cough

b)

Rash

c)

Constipation

d)

Insomnia

53.

Why are ARBs preferred over ACE inhibitors in patients with a history of angioedema?

a)

ARBs do not increase bradykinin levels

b)

ARBs are more effective in lowering blood pressure

c)

ARBs have fewer drug interactions

d)

ARBs are less expensive

54.

What should be monitored in patients taking sacubitril/valsartan?

a)

Blood pressure, renal function, signs/symptoms of heart failure, angioedema

b)

Liver enzymes, cholesterol, blood glucose, vision

c)

Heart rate, respiratory rate, temperature, weight

d)

Potassium, calcium, magnesium, sodium

55.

Which enzyme do ACE inhibitors block the conversion of?

a)

Angiotensin I to angiotensin II

b)

Aldosterone to renin

c)

Bradykinin to angiotensin I

d)

Renin to aldosterone

56.

What is a common side effect associated with ACE inhibitors due to the degradation of bradykinin?

a)

Cough and angioedema

b)

Hypertension

c)

Hyperglycemia

d)

Constipation

57.

Which ACE inhibitor has a boxed warning for causing injury and death to the developing fetus when used in the 2nd and 3rd trimesters?

a)

Captopril

b)

Losartan

c)

Valsartan

d)

Candesartan

58.

What is the recommended washout period when switching between an ACE inhibitor and ARNI?

a)

36 hours

b)

12 hours

c)

24 hours

d)

48 hours

59.

Which ARB does NOT require a washout period when switching with sacubitril/valsartan?

a)

Valsartan

b)

Candesartan

c)

Losartan

d)

Ramipril

60.

Why should more than one RAAS inhibitor not be used together?

a)

Increased risk of renal impairment, hypotension, and hyperkalemia

b)

Increased risk of cough and headache

c)

Increased risk of bradycardia and hypoglycemia

d)

Increased risk of constipation and diarrhea

61.

Which of the following is a contraindication for the use of ACE inhibitors?

a)

History of angioedema

b)

History of hypertension

c)

History of diabetes

d)

History of cough

62.

What should be monitored when a patient is on ACE inhibitors?

a)

Blood pressure, potassium, renal function, symptoms of heart failure, angioedema

b)

Blood glucose, cholesterol, liver enzymes, weight

c)

Heart rate, respiratory rate, temperature, vision

d)

Calcium, magnesium, sodium, uric acid

63.

A patient is switching from an ACE inhibitor to an ARNI. What is the most important step to prevent adverse effects?

a)

Ensure a 36-hour washout period

b)

Double the dose of ARNI

c)

Stop all potassium supplements

d)

Add a diuretic immediately

64.

Which drug interaction can increase the risk of lithium toxicity when used with ACE inhibitors or ARBs?

a)

Decreased lithium renal clearance

b)

Increased potassium excretion

c)

Increased sodium absorption

d)

Decreased aldosterone secretion

65.

Which of the following is a primary effect of beta-blockers on the cardiovascular system?

a)

Improve cardiac function and lower morbidity and mortality

b)

Increase catecholamine release

c)

Stimulate alpha-1 adrenergic receptors

d)

Cause severe hypertension in all patients

66.

Which beta-blockers are recommended as first-line therapy for heart failure (HF) patients?

a)

Bisoprolol, carvedilol, and metoprolol succinate ER

b)

Atenolol, propranolol, and metoprolol tartrate

c)

Labetalol, nadolol, and acebutolol

d)

Only metoprolol tartrate and bisoprolol

67.

What is the boxed warning associated with metoprolol succinate extended release?

a)

Do not discontinue abruptly; gradually taper over 1-2 weeks

b)

May cause severe hepatic impairment

c)

Take with food to increase absorption

d)

Can cause intraoperative floppy iris syndrome

68.

Which of the following is a contraindication for the use of carvedilol?

a)

Severe hepatic impairment

b)

Diabetes mellitus

c)

Mild hypertension

d)

Hyperthyroidism

69.

A patient with bronchospastic disease such as asthma or COPD should use which beta-blocker with caution?

a)

Metoprolol succinate extended release

b)

Atenolol

c)

Bisoprolol

d)

All of the above

70.

Which side effect is common to both metoprolol and bisoprolol?

a)

Bradycardia

b)

Edema

c)

Severe hepatic impairment

d)

Cataract formation

71.

A patient is being switched from carvedilol immediate release (IR) to controlled release (CR). What should be considered regarding dose conversion?

a)

Dose conversions are not 1:1 between IR and CR

b)

CR is always given at a lower dose than IR

c)

IR and CR can be used interchangeably at the same dose

d)

CR is not recommended for heart failure

72.

Which of the following is a warning specific to carvedilol use in patients undergoing cataract surgery?

a)

Intraoperative floppy iris syndrome

b)

Severe bradycardia

c)

Masking of hypoglycemia

d)

Impotence

73.

A patient with Raynaud’s disease is prescribed a beta-blocker. What should the healthcare provider consider?

a)

Use caution, as beta-blockers can exacerbate Raynaud’s symptoms

b)

Beta-blockers are contraindicated in Raynaud’s disease

c)

Beta-blockers will improve Raynaud’s symptoms

d)

No special considerations are needed

74.

Which of the following is a potential effect of beta-blocker drug interactions with insulin and sulfonylureas?

a)

Enhanced hyperglycemia

b)

Enhanced hypoglycemia

c)

Increased blood pressure

d)

Decreased risk of anxiety

75.

Which SGLT2 inhibitor is recommended first line for all patients with heart failure and has a fixed dose that does not require titration?

a)

Metoprolol

b)

Digoxin

c)

Dapagliflozin (Farxiga)

d)

Spironolactone

76.

What is the main mechanism by which aldosterone receptor antagonists (ARAs) help in heart failure?

a)

Increase sodium and water retention

b)

Compete with aldosterone at receptor sites in the distal convoluted tubule

c)

Inhibit CYP450 enzymes

d)

Stimulate cardiac remodeling

77.

Which of the following is a contraindication for the use of spironolactone?

a)

Hyperkalemia

b)

Hypokalemia

c)

Hypertension

d)

Diabetes mellitus

78.

A patient with heart failure and an eGFR of 18 mL/min/1.73 m² is being considered for SGLT2 inhibitor therapy. What should be done?

a)

Initiate SGLT2 inhibitor at standard dose

b)

Initiate SGLT2 inhibitor at half dose

c)

Do not initiate SGLT2 inhibitor

d)

Increase the dose of SGLT2 inhibitor

79.

Which side effect is associated with spironolactone but not with eplerenone?

a)

Hyperkalemia

b)

Gynecomastia

c)

Dizziness

d)

Hyperchloremic metabolic acidosis

80.

Why should caution be used when combining beta-blockers with drugs that lower heart rate (HR)?

a)

It may cause severe hypertension

b)

It may lead to excessive bradycardia

c)

It increases the risk of hyperglycemia

d)

It causes increased anxiety

81.

Explain why eplerenone is preferred over spironolactone in patients concerned about endocrine side effects.

a)

Eplerenone is more potent

b)

Eplerenone does not exhibit endocrine side effects

c)

Eplerenone is less effective

d)

Eplerenone increases sodium retention

82.

Which of the following is a risk when combining an ACE inhibitor, ARB or ARNI, and an ARA?

a)

Increased risk of hyperkalemia and renal insufficiency

b)

Decreased risk of dehydration

c)

Increased risk of hypokalemia

d)

Decreased risk of hypertension

83.

What is the primary action of loop diuretics in the nephron?

a)

Inhibit the Na-K-2Cl cotransporter in the thick ascending limb of the loop of Henle

b)

Stimulate sodium reabsorption in the distal tubule

c)

Inhibit aldosterone in the collecting duct

d)

Increase water reabsorption in the proximal tubule

84.

Which of the following is NOT a common side effect of loop diuretics?

a)

Hypercalcemia

b)

Hypokalemia

c)

Hypomagnesemia

d)

Hyponatremia

85.

A patient with a known sulfa allergy is prescribed a loop diuretic. Which loop diuretic is least likely to cross-react?

a)

Ethacrynic acid

b)

Furosemide

c)

Bumetanide

d)

Torsemide

86.

Which of the following statements best explains why loop diuretics are often required for symptom control in heart failure, even though they do not improve survival?

a)

They reduce congestive symptoms by increasing excretion of sodium, potassium, chloride, magnesium, calcium, and water, making it easier for the heart to pump.

b)

They directly increase cardiac contractility.

c)

They reduce blood pressure by vasodilation.

d)

They increase preload to improve cardiac output.

87.

Which of the following is the correct oral equivalent dosing for loop diuretics?

a)

Furosemide 40 mg = Torsemide 20 mg = Bumetanide 1 mg = Ethacrynic acid 50 mg

b)

Furosemide 20 mg = Torsemide 40 mg = Bumetanide 2 mg = Ethacrynic acid 25 mg

c)

Furosemide 80 mg = Torsemide 40 mg = Bumetanide 2 mg = Ethacrynic acid 100 mg

d)

Furosemide 10 mg = Torsemide 5 mg = Bumetanide 0.5 mg = Ethacrynic acid 12.5 mg

88.

A patient is experiencing hearing loss and tinnitus after rapid IV administration of a loop diuretic. Which drug is most likely responsible?

a)

Bumetanide

b)

Spironolactone

c)

Hydrochlorothiazide

d)

Amiloride

89.

Why should loop diuretics generally be taken early in the day?

a)

To avoid nocturia

b)

To prevent hyperglycemia

c)

To reduce risk of photosensitivity

d)

To increase absorption

90.

Which laboratory value is most likely to increase with loop diuretic use?

a)

Bicarbonate (HCO3)

b)

Calcium

c)

Potassium

d)

Sodium

91.

A patient is prescribed furosemide injection. What is an important storage instruction?

a)

Store at room temperature; solution must be clear, do not use if yellow in color

b)

Store in the freezer; use only if solution is cloudy

c)

Store in direct sunlight; use if solution is yellow

d)

Store in the refrigerator; use if solution is cloudy

92.

Which of the following drugs should be avoided when using loop diuretics due to the risk of decreasing sodium and water retention and causing renal impairment?

a)

NSAIDs

b)

ACE inhibitors

c)

Beta-blockers

d)

Calcium channel blockers

93.

What is the main risk when loop diuretics are used in combination with other ototoxic drugs?

a)

Additive risk for ototoxicity

b)

Increased risk of hypertension

c)

Reduced diuretic effect

d)

Increased risk of hyperkalemia

94.

A patient is being treated with furosemide 40 mg IV BID for acute heart failure exacerbation. What is the equivalent daily oral dose of bumetanide?

a)

4 mg PO bumetanide

b)

8 mg PO bumetanide

c)

2 mg PO bumetanide

d)

10 mg PO bumetanide

95.

Hydralazine is classified as which type of drug?

a)

Direct arterial vasodilator

b)

Beta-blocker

c)

ACE inhibitor

d)

Loop diuretic

96.

Which combination is indicated in self-identified Black patients with heart failure who remain symptomatic despite optimal treatment?

a)

Hydralazine/isosorbide dinitrate

b)

ACE inhibitor/ARB

c)

Beta-blocker/diuretic

d)

Calcium channel blocker/nitrate

97.

What is a major contraindication for hydralazine use?

a)

Mitral valve rheumatic heart disease

b)

Diabetes mellitus

c)

Asthma

d)

Chronic kidney disease